Navigation Links
PhUSE Working Group Active in Developing Standard Analysis Scripts
Date:1/12/2014

Silver Spring, Maryland (PRWEB) January 12, 2014

The PhUSE Computational Science Symposium Working Group on the development of Standard Scripts has been active in 2013 in pursuing its goal to begin standardizing clinical data analyses across the Pharmaceutical and Biotech industries. The working group comprises members from industry and academia, and receives input from the US Food and Drug Administration.

In October, the Working Group announced the release of its first white paper, providing advice on Central Tendency Analyses with a focus on Safety. The white paper release provided recommended standard tables and figures for measures of central tendency for a common set of safety measurements.

The authors of the white paper gave insight into the value of standard analysis scripts, stating that "Development of standard Tables, Figures, and Listings (TFLs) and associated analyses will lead to improved standardization from collection through data storage … the development of standard TFLs will also lead to improved product lifecycle management by ensuring reviewers receive the desired analyses for the consistent and efficient evaluation of patient safety and drug effectiveness."

The white paper on Central Tendency Analyses will be used as basis for PhUSE's first ever "Script-athon," to be held at the PhUSE Computational Sciences Symposium, in March 2014, in Silver Spring, Maryland, USA. The Script-athon will challenge programmers to collaborate to create standard scripts using code languages such as SAS and R. Targets for standard analysis and reporting scripts will be selected from the white paper. PhUSE supports an open and collaborative environment, and the outputs of the Script-athon will be stored in the PhUSE Standard Scripts working group code repository.

In addition to hosting the Script-athon, the working group will continue to focus on the creation of further white papers in 2014. The working group is keen to engage new voices from industry and academia to contribute to this work.

The important work conducted in 2013 is "…connected to strategic goal that PhUSE becomes the industry voice to regulatory agencies and standards organizations," said Mary Nilsson, industry co-lead of the Standard Scripts working group.

ABOUT PhUSE
PhUSE, Share – Contribute – Advance, provides the industry with the premier platform for creating and sharing ideas, tools and standards around data, statistical and reporting technologies; PhUSE is a non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical data science. Since its inception, PhUSE has expanded from its roots as a conference for European Statistical Programmers, to a global platform for the discussion of topics encompassing the work of Data Managers, Biostatisticians, Statistical Programmers and clinical data scientists.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11479174.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. PhUSE Co-sponsors the Annual FDA/PhUSE Computational Science Symposium, in Silver Spring Maryland, USA, March 18th-19th 2013
2. PhUSE Annual Conference to focus on Patient Centricity
3. Moffitt Cancer Center researchers working at frontiers of melanoma research
4. Doctors cite concern for patients, colleagues top motives for working sick
5. DotComSecrets Invites Professionals to Learn Great Tips On How to Make a Handsome Income By Working As Local Internet Marketing Consultants
6. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
7. New Home Energy Savings Device Poised to Help Thousands Succeed Working from Home
8. Why current strategies for fighting obesity are not working
9. New Yorks Trans-Fat Ban Is Working: Study
10. Working toward an AIDS-free generation
11. Tumor cells inner workings predict cancer progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Dr. Benjamin Stong of Kalos Facial ... treatment. Dr. Stong is double board certified and the only facial plastic surgeon ... of hair loss. Non-surgical therapies such as stem cells can be used to provide ...
(Date:5/5/2016)... ... May 05, 2016 , ... In honor of National Nurses ... people all over the United States to thank a nurse who's made a difference ... donate $5 to the American Red Cross of San Diego/Imperial Counties (up to $10,000) ...
(Date:5/5/2016)... ... May 05, 2016 , ... Chronic stress can have a silent, ... can weaken the immune system and increase inflammation, both of which raise the risk ... adult congenital heart disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also can ...
(Date:5/5/2016)... N.J. (PRWEB) , ... May 05, 2016 , ... ... patients with cancer, today announced a new collaboration with Imerman Angels to ... cancer anywhere in the world. , “Imerman Angels provides an emotional lifeline to patients ...
(Date:5/5/2016)... ... May 05, 2016 , ... Dermatologic surgeons performed nearly 10 million ... up 27 percent since 2012. , The results of the 2015 ASDS Survey on ... in skin cancer treatments and the growing popularity of soft-tissue fillers and body sculpting ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016  Compass Diversified Holdings (NYSE: CODI ... of leading middle market businesses, announced today its consolidated ... 2016. First Quarter 2016 Highlights , ... or "Cash Flow") of $13.6 million for the first ... $15.0 million for the first quarter of 2016; ...
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Myeloid Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Myeloid Leukemia epidemiology, Acute Myeloid ...
Breaking Medicine Technology: